Amanote Research
Register
Sign In
Fibroblast Growth Factor Receptor 1 (FGFR1; CD331), FGFR2 and Fibroblast Growth Factor 19 (FGF19) Amplification May Help Predict Sensitivity to FGFR Inhibitors in Cancer
Science-Business eXchange
doi 10.1038/scibx.2012.1067
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2012
Authors
Unknown
Publisher
Springer Science and Business Media LLC